SUSAN K. LANGER

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

BIOGEN INC.

Filing Date Source Excerpt
2024-04-26 Susan Langer, President & Chief Business Officer at Souffle Therapeutics Director since 2023 Age 33 ... 2023 Director Compensation Table shows $334,534 total compensation.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22